FDA Accepts BrainStorm’s NurOwn IND Application for Progressive Multiple Sclerosis
BrainStorm Cell Therapeutics (NASDAQ:BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, announced that the...
Cancer Genetics Terminates Proposed Merger with NovellusDx
Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today...
Innovate Biopharmaceuticals Plans to Commence the First Ever Phase 3 Registration Trial in Celiac Disease
Innovate Biopharmaceuticals (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory diseases, is evaluating...
Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma
Atara Biotherapeutics (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral...
Life Science Big News Roundup: NanoSphere Forms Strategic Partnership in Mexico; Chemesis International Inc. Announces Approval of OTCQB Uplisting
In case you missed it, here is this week’s life science big news roundup.
Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement
Orchard Therapeutics (NASDAQ:ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare...
Green Growth Brands to Acquire Option for Medical and Retail Dispensary in Henderson, Nevada
Xanthic Biopharma (CSE:xTHC) d/b/a Green Growth Brands (CSE: GGB) (GGB or the Company) announced today that it has agreed to accept...